OM DENNE EPISODE
In this episode of The Connect Current, host James Zanewicz sits down with Rupak Doshi, Co-founder and CEO of OmniSync, to explore how better systems can accelerate innovation. Rupak shares how OmniSync is helping founders and organizations navigate funding, market intelligence, and commercialization through AI-powered tools, and why the path from idea to traction is still more fragmented than it should be. He also offers insight into where innovators lose the most time and how smarter infrastructure can unlock faster progress.
This conversation is a focused look at the systems behind innovation and what it takes to move more ideas from concept to real-world impact.
This podcast was recorded at UC San Diego Park & Market.
Engelsk
USA
UDSKRIFT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SØG BLANDT TIDLIGERE EPISODER
Søg efter gamle afsnit af The Connect Current.
ANDRE EPISODE I DENNE PODCAST
In this episode of The Connect Current, we sit down with Graeme Rae, Ph.D., Founder and CEO of HyperKelp, to explore how the company is turning the ocean into a sensing network. Graeme shares how HyperKelp’s Kelp Smart Buoy is designed as an open marine platform that can carry a wide range of senso…
In this episode of The Connect Current, host James Zanewicz sits down with Debbie Chen, Founder and CEO of Hydrostasis, to explore how nontraditional journeys are shaping the next generation of innovation. Debbie shares how Hydrostasis is advancing hydration science through wearable technology, and…
In this episode of The Connect Current, host James Zanewicz sits down with Adam Jacobs, President of Xzom, to explore how early disease detection and accessible diagnostics are shaping the future of health innovation. Adam shares how Xzom is building point-of-care solutions designed to make diagnos…
In this episode of The Connect Current, host James Zanewicz is joined by Courtney Young, PhD, Co-founder and CEO of MyoGene Bio, one of Connect's 2026 Cool Companies. MyoGene Bio is developing MyoDys45-55, an AAV-delivered CRISPR gene editing therapy for Duchenne muscular dystrophy, a rare and deva…
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra Connect, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.
REDIG
Tak fordi du hjælper med at holde podcast-databasen opdateret.